Physician profile
Steven L Dary
NPI 1538629753
$1,406.53
in general payments reported to CMS, 2019-2025
21 companies · $89.50 in 2025
The $89.50 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $570 · 2023: $154 · 2024: $414 · 2025: $89.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $172.93 | 2024-2025 | Uzedy, Austedo Xr |
| Sanofi-Aventis U.S. LLC | $141.30 | 2022 | |
| Novo Nordisk INC | $137.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $133.95 | 2021-2022 | |
| Glaxosmithkline, LLC. | $130.21 | 2022 | |
| Gilead Sciences, INC. | $124.95 | 2022 | |
| Pharming Healthcare, INC. | $124.65 | 2024 | Joenja |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $64.41 | 2024-2025 | Caplyta |
| Abbvie INC. | $57.04 | 2023 | |
| Alkermes, INC. | $52.46 | 2024 | Aristada, Lybalvi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.02 | 2021 | |
| Edwards Lifesciences Corporation | $49.90 | 2023 | Sapien 3 Ultra Resilia |
| Janssen Biotech, INC. | $31.39 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $20.91 | 2025 | Invega Sustenna |
| E.R. Squibb & Sons, L.L.C. | $20.80 | 2025 | Cobenfy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $18.52 | 2024 | Fanapt |
| Amgen INC. | $17.47 | 2023 | Prolia, Evenity |
| Lilly USA, LLC | $15.61 | 2023 | Mounjaro |
| Lundbeck LLC | $15.14 | 2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $14.29 | 2023 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $13.44 | 2024 | Abilify Asimtufii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.